CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 546.00
-9.00 (-1.62%)
Jun 24, 2026, 1:00 PM JST
CanBas Market Cap
CanBas has a market cap or net worth of 10.61 billion as of June 23, 2026. Its market cap has decreased by -46.27% in one year.
Market Cap
10.61B
Enterprise Value
8.84B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
546.00
Market Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 10.61B, an increase of 26.54%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 10.61B | -30.88% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 13.46B |
| Stella Pharma | 12.33B |
| ReproCELL | 11.97B |
| Immuno-Biological Laboratories | 8.69B |
| Kubota Pharmaceutical Holdings | 8.30B |
| Nano Holdings | 8.28B |
| CellSeed | 8.19B |
| OncoTherapy Science | 8.06B |